Senior Vice President, Business and Corporate Development · Cytek Biosciences, Inc. (CTKB)

Allen Poirson

FY2023 is the first fiscal year CompBrief holds for Allen Poirson as a named executive officer of Cytek Biosciences; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2023

$1,426,276

Salary $413,000Stock awards $425,000

5th of 5 named executive officers at Cytek Biosciences by FY2023 total.

5 named officers on file for Cytek Biosciences, FY2023

Allen Poirson’s pay file — $29

  • 1 fiscal year of pay, line by line
  • 2 equity grants, each cited to its filing
  • CTKB’s disclosed peer group of 16 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Cytek Biosciences’s whole pay program stands against its peers

  • Cytek Biosciences’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on CTKB→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 25, 2024 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get Allen Poirson’s full pay file as a PDF — free

More than this page: up to 10 years of Allen’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Allen Poirson compensation by year

Cytek Biosciences Summary Compensation Table · the one fiscal year held
In US dollars, as Cytek Biosciences reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2023
Salary$413,000
Bonus$0
Stock awards$425,000
Option awards$425,000
Non-equity incentive$118,664
Pension and deferred compensation$0
All other$44,612
Total$1,426,276

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Cytek Biosciences, Inc. DEF 14A filed April 25, 2024, accession 0001140361-24-022063, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Cytek Biosciences, Inc. filed document, accession 0001140361-24-022063. Every figure is read from that document and cited to the page and table it appears in. Filed April 25, 2024.

Equity holdings

unvested awards at FY2023 year-end
TypeUnvested unitsValue at year-endExercise price
RSU33,381$304,435—
RSU6,853$62,499—
Option53,332—$4.71
Option29,688—$17.00
Option9,939—$13.64
Option49,190—$10.61

Per the Outstanding Equity Awards at Fiscal Year-End table in Cytek Biosciences, Inc.'s FY2023 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

27 Form 4 lines since the FY2023 proxy (filed April 25, 2024)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2024-11-18Exercise or conversion—1,878—60,713
2024-11-18Tax withholding—732$6.0359,981
2024-11-18Exercise or conversion—2,503—59,810
2024-11-18Exercise or conversion—790—57,615
2024-11-18Exercise or conversion derivative—1,878$0.0025,048
2024-11-18Tax withholding—975$6.0358,835
2024-11-18Tax withholding—308$6.0357,307
2024-11-18Exercise or conversion derivative—790$0.003,693

The 8 most recent of 27 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

Cytek Biosciences’s named executive officers, FY2023

as the company reported each
Named executive officerRoleFY2023 total
Wenbin JiangChief Executive Officer and President$4,939,242
Ming YanChief Technology Officer$3,070,122
Valerie BarnettChief Legal Officer and Corporate Secretary$1,862,394
Patrik JeanmonodChief Financial Officer$1,786,088
Allen Poirson · this pageSenior Vice President, Business and Corporate Development$1,426,276

Board service

Cytek Biosciences board · FY2021

How this board is paid

Company policy: Cytek Biosciences pays directors a $40,000 cash retainer and $160,000 in equity. As stated in Cytek Biosciences's FY2021 proxy.

The full Cytek Biosciences compensation record

free company brief

This page is one person within Cytek Biosciences's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Cytek Biosciences proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Cytek Biosciences's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Allen Poirson's compensation dossier · One-time report. No refunds.